DTIL logo

Precision BioSciences (DTIL)

Profile

Full Name

Precision BioSciences, Inc.

Ticker Symbol

DTIL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 28, 2019

Indexes

Not included

Website

http://www.precisionbiosciences.com

Employees

108

Key Details

Price

$5.02(+0.20%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$68.70M(+40.98% YoY)

Annual EPS

$1.04(+106.52% YoY)

PE ratio

3.64

Next earnings date

May 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$5.02
DTIL price is $5.02

30-Day Relative Volume

0.52
DTIL 30-day relative volume is 0.52

Price Performance

Price Today change

+0.2%
DTIL price is up +0.2% today

Price YTD change

+31.76%
DTIL price is up +31.76% since January 1st

Price 1-year change

-56.39%
DTIL price is down -56.39% year-on-year

Price 3-year change

-93.73%
DTIL price is down -93.73% over the past 3 years

Price Range

Price All-time high

$710.10
DTIL price is currently -99.29% below its historical high of $710.10

Price 3-year low

$3.61
DTIL price is currently +39.06% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$52.62M
DTIL market capitalization is $52.62 million

Market cap 3-year change

-68.1%
DTIL market capitalization is down -68.1% over the past 3 years

Market cap All-time high

$998.47M
DTIL market capitalization is currently -94.73% below its historical high of $998.47 million

Market cap sector rank

38.73%
DTIL market capitalization is higher than 38.73% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+51.56%
DTIL shares outstanding is up +51.56% year-on-year

Shares Outstanding 3-Year Change

+409.03%
DTIL shares outstanding is up +409.03% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.29
DTIL beta is 0.29

200-day SMA

$7.20
DTIL price is currently -30.26% below its 200-day simple moving average

50-day SMA

$5.03
DTIL price is currently -0.21% below its 50-day simple moving average

RSI

52.85
DTIL 14-day relative strength index is 52.85

Volume

0.52
DTIL 30-day relative volume is 0.52

ATR

$0.39
DTIL average true range is $0.39

10-day Historical Volatility

145.94%
DTIL 10-day historical volatility is 145.94%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$68.70M
DTIL annual revenue is $68.70 million

Revenue Analysts estimate

$17.73M
DTIL annual revenue is currently +287.57% higher than the consensus analysts' forecast

Revenue 1-year change

+40.98%
DTIL annual revenue is up +40.98% year-on-year

Revenue Sector rank

51.4%
DTIL annual revenue is higher than 51.4% of companies in Healthcare sector

EPS

EPS

$1.04
DTIL annual earnings per share is $1.04

EPS Analysts estimate

-$10.22
DTIL annual earnings per share is currently -110.18% lower than the consensus analysts' forecast

EPS 1-year change

+106.52%
DTIL annual earnings per share is up +106.52% year-on-year

EPS Sector rank

89.59%
DTIL annual earnings per share is higher than 89.59% of companies in Healthcare sector

Profit

Gross profit

-
DTIL annual gross profit value is unknown

Gross margin

-
DTIL annual gross profit margin value is unknown

Operating profit

-$26.16M
DTIL annual operating income is -$26.16 million

Operating margin

-38.08%
DTIL annual operating profit margin is -38.08%

Net income

$7.17M
DTIL annual net profit is $7.17 million

Net margin

10.43%
DTIL annual net profit margin is 10.43%

Expenses

Total expenses

$94.86M
DTIL annual total expenses is $94.86 million

Operating expenses

$94.86M
DTIL annual total operating expenses is $94.86 million

Cost of goods sold

-
DTIL annual cost of goods sold value is unknown

Selling, general & administrative expenses

$35.30M
DTIL annual SGA is $35.30 million

Depreciation and amortization

$4.58M
DTIL annual depreciation & amortization is $4.58 million

Interest expense

$1.78M
DTIL annual interest expense is $1.78 million

Income tax

-
DTIL annual income tax value is unknown

EBIT & EBITDA

EBIT

$8.95M
DTIL annual earnings before interest & taxes is $8.95 million

EBITDA

$13.53M
DTIL annual EBITDA is $13.53 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$136.39M
DTIL annual total assets is $136.39 million

Non current assets

$41.40M
DTIL annual long term assets is $41.40 million

Current assets

$94.99M
DTIL annual total current assets is $94.99 million

Cash and cash equivalents

$85.90M
DTIL annual cash & cash equivalents is $85.90 million

Accounts receivable

$229.00K
DTIL annual accounts receivable is $229.00 thousand

Inventory

-
DTIL annual inventory value is unknown

Liabilities

Total liabilities

$80.00M
DTIL annual total liabilities is $80.00 million

Long term liabilities

$65.02M
DTIL annual total long term liabilities is $65.02 million

Current liabilities

$14.98M
DTIL annual total current liabilities is $14.98 million

Accounts payable

$1.31M
DTIL annual accounts payable is $1.31 million

Debt

Total debt

$30.05M
DTIL annual total debt is $30.05 million

Total debt 1-year change

-3.91%
DTIL annual total debt is down -3.91% year-on-year

Long term debt

$28.73M
DTIL annual long term debt is $28.73 million

Short term debt

$1.32M
DTIL annual short term debt is $1.32 million

Equity & Capital

Shareholders equity

$56.39M
DTIL annual stockholders equity is $56.39 million

Book value

$56.39M
DTIL annual book value is $56.39 million

Retained earnings

-$482.46M
DTIL annual retained earnings is -$482.46 million

Working capital

$80.01M
DTIL annual working capital is $80.01 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$58.45M
DTIL annual cash flow from operations is -$58.45 million

Cash from operations 1-year change

+30.52%
DTIL annual cash flow from operations is up +30.52% year-on-year

Cash from investing

-$215.00K
DTIL annual cash flow from investing activities is -$215.00 thousand

Cash from investing 1-year change

-103.69%
DTIL annual cash flow from investing activities is down -103.69% year-on-year

Cash from financing

$50.45M
DTIL annual cash flow from financing activities is $50.45 million

Cash from financing 1-year change

+836.51%
DTIL annual cash flow from financing activities is up +836.51% year-on-year

CAPEX

CAPEX

$275.00K
DTIL annual capital expenditures is $275.00 thousand

CAPEX 1-year change

-87.93%
DTIL annual capital expenditures is down -87.93% year-on-year

Free Cash Flow

Free cash flow

-$58.72M
DTIL annual free cash flow is -$58.72 million

Free cash flow 1-year change

+32.03%
DTIL annual free cash flow is up +32.03% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
DTIL annual gross profit margin value is unknown

Operating margin

-38.08%
DTIL annual operating profit margin is -38.08%

Net margin

10.43%
DTIL annual net profit margin is 10.43%

ROA & ROE

ROA

4.84%
DTIL annual return on assets is 4.84%

ROE

19.05%
DTIL annual return on equity is 19.05%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

3.64
DTIL price to earnings ratio is 3.64

PE ratio Sector rank

5.39%
DTIL price to earnings ratio is higher than 5.39% of companies in Healthcare sector

PB Ratio

PB ratio

0.93
DTIL price to book ratio is 0.93

PB ratio Sector rank

42.67%
DTIL price to book ratio is higher than 42.67% of companies in Healthcare sector

PS Ratio

PS ratio

0.77
DTIL price to sales ratio is 0.77

PS ratio Sector rank

23.59%
DTIL price to sales ratio is higher than 23.59% of companies in Healthcare sector

Enterprise value

Enterprise value

-$3.23M
DTIL enterprise value is -$3.23 million

Enterprise value Sector rank

7.35%
DTIL enterprise value is higher than 7.35% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.24
DTIL EV/EBITDA is -0.24

EV/EBITDA Sector rank

57.48%
DTIL EV/EBITDA is higher than 57.48% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.34
DTIL annual current ratio is 6.34

Quick ratio

-
DTIL annual quick ratio value is unknown

Leverage

Debt to equity

0.40
DTIL annual debt to equity ratio is 0.40

Interest coverage ratio

5.02
DTIL annual interest coverage ratio is 5.02

Risk & Stability

Piotroski F-Score

-
DTIL piotroski f-score value is unknown

Altman Z-Score

-3.13
DTIL altman z-score is -3.13

Analyst ratings

Recent major analysts updates

Mar 28, 25 HC Wainwright & Co.
Buy
Mar 19, 25 HC Wainwright & Co.
Buy
Feb 19, 25 HC Wainwright & Co.
Buy
Jan 10, 25 HC Wainwright & Co.
Buy
Jan 10, 25 BMO Capital
Outperform
May 30, 24 HC Wainwright & Co.
Buy
May 16, 24 HC Wainwright & Co.
Buy
Apr 30, 24 Guggenheim
Buy
Apr 17, 24 HC Wainwright & Co.
Buy
Mar 28, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

Cibus (CBUS)
SER logo
Serina Therapeutics (SER)
HYPR logo
Hyperfine (HYPR)
PMVP logo
PMV Pharmaceuticals (PMVP)
IKNA logo
Ikena Oncology (IKNA)
KRON logo
Kronos Bio (KRON)
OWLT logo
Owlet (OWLT)
BYSI logo
BeyondSpring (BYSI)
GUTS logo
Fractyl Health (GUTS)
  • What is the ticker symbol for Precision BioSciences?
  • Does Precision BioSciences pay dividends?
  • What sector is Precision BioSciences in?
  • What industry is Precision BioSciences in?
  • What country is Precision BioSciences based in?
  • When did Precision BioSciences go public?
  • Is Precision BioSciences in the S&P 500?
  • Is Precision BioSciences in the NASDAQ 100?
  • Is Precision BioSciences in the Dow Jones?
  • When was Precision BioSciences's last earnings report?
  • When does Precision BioSciences report earnings?
  • Should I buy Precision BioSciences stock now?

What is the ticker symbol for Precision BioSciences?

The ticker symbol for Precision BioSciences is NASDAQ:DTIL

Does Precision BioSciences pay dividends?

No, Precision BioSciences does not pay dividends

What sector is Precision BioSciences in?

Precision BioSciences is in the Healthcare sector

What industry is Precision BioSciences in?

Precision BioSciences is in the Biotechnology industry

What country is Precision BioSciences based in?

Precision BioSciences is headquartered in United States

When did Precision BioSciences go public?

Precision BioSciences's initial public offering (IPO) was on March 28, 2019

Is Precision BioSciences in the S&P 500?

No, Precision BioSciences is not included in the S&P 500 index

Is Precision BioSciences in the NASDAQ 100?

No, Precision BioSciences is not included in the NASDAQ 100 index

Is Precision BioSciences in the Dow Jones?

No, Precision BioSciences is not included in the Dow Jones index

When was Precision BioSciences's last earnings report?

Precision BioSciences's most recent earnings report was on Mar 26, 2025

When does Precision BioSciences report earnings?

The next expected earnings date for Precision BioSciences is May 13, 2025

Should I buy Precision BioSciences stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page